Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
  6. News
  7. Summary
    600196   CNE000000X38

SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.

(600196)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Shanghai Fosun Pharmaceutical : Fosun Pharma Wins US FDA Nod to Start Clinical Trial of Experimental Heart Failure Treatment

09/21/2021 | 09:28pm EDT


© MT Newswires 2021
All news about SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
01:44aSHANGHAI FOSUN PHARMACEUTICAL : Chinese Regulators Approve Fosun Pharma's Clinical Trial o..
MT
10/20SHANGHAI FOSUN PHARMACEUTICAL : Tridem Pharma's First Regional Pharmaceutical Distribution..
PU
10/20SHANGHAI FOSUN PHARMACEUTICAL : Overseas Regulatory Announcement (H Shares)
PU
10/14SHANGHAI FOSUN PHARMACEUTICAL : Date of board meeting(h shares)
PU
10/13SHANGHAI FOSUN PHARMACEUTICAL : Helsinn and Fosun Pharma sign exclusive license and distri..
AQ
10/12SHANGHAI FOSUN PHARMACEUTICAL : Fosun Pharma Setting Up Children-Focused Medical Services ..
MT
10/11SHANGHAI FOSUN PHARMACEUTICAL : Connected transaction - formation of joint venture (h shar..
PU
10/11Fosun Health Enters Joint Venture Agreement with Forte Industrial Development
CI
10/07SHANGHAI FOSUN PHARMACEUTICAL : Monthly return of equity issuer on movements in securities..
PU
10/01SHANGHAI FOSUN PHARMACEUTICAL : Asian Private Equity Firm CBC to Buy 43% Stake in Yaneng B..
MT
More news
Analyst Recommendations on SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
More recommendations
Financials
Sales 2021 36 500 M 5 705 M 5 705 M
Net income 2021 5 008 M 783 M 783 M
Net Debt 2021 17 898 M 2 797 M 2 797 M
P/E ratio 2021 28,4x
Yield 2021 0,99%
Capitalization 120 B 18 729 M 18 714 M
EV / Sales 2021 3,77x
EV / Sales 2022 3,21x
Nbr of Employees 34 375
Free-Float 58,7%
Chart SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
Duration : Period :
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 52,29 CNY
Average target price 70,00 CNY
Spread / Average Target 33,9%
EPS Revisions
Managers and Directors
Xiao Hui Guan Executive President & Chief Financial Officer
Yu Qing Chen Co-President
Ke Xin Wang Co-President
Dong Ming Li Co-President
Yi Fang Wu Chairman